JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B4902 (+)-Apogossypol

Target: Bcl-2

Summary: inhibitor of Bcl-2 family proteins

insoluble in H2O; ≥16.2 mg/mL
B5978 BDA-366

Target: Bcl-2

Summary: Selective antagonist of BCL2 BH4 domain

≥50.4 mg/mL
A8168 HA14-1

Target: Bcl-2

Summary: Bcl-2 inhibitor,potent and cell-permeable

insoluble in H2O; ≥20.45 mg/mL
A3007 ABT-263 (Navitoclax)
15 Citation

Target: Bcl-2|Bcl-w

Summary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w

≥48.73 mg/mL
A4234 TW-37
1 Citation

Target: Bcl-2|Bcl-xl|Mcl-1

Summary: Bcl-2 inhibitor, inhibits Bcl-2,Bcl-XL and Mcl-1

insoluble in H2O; ≥19.75 mg/mL
A4194 Obatoclax mesylate (GX15-070)
1 Citation

Target: Bcl-2

Summary: Potent Bcl-2 inhibitor

insoluble in H2O; ≥20.7 mg/mL
A4200 Apogossypolone (ApoG2)
2 Citation

Target: Bcl-2|Bcl-xl|Mcl-1

Summary: Bcl-2 inhibitor,nonpeptidic small molecule

≥24.55 mg/mL
A4199 Sabutoclax
2 Citation

Target: Bcl-2|Mcl-1|Bfl-1

Summary: pan-Bcl-2 inhibitor

insoluble in H2O; ≥205.6 mg/mL